104 related articles for article (PubMed ID: 1995194)
1. Magnetic resonance imaging compared with hormonal effects and histopathology of estrogen-induced pituitary lesions in the rat.
van Nesselrooij JH; Bruijntjes JP; van Garderen-Hoetmer A; Tillapaugh-Fay GM; Feron VJ
Carcinogenesis; 1991 Feb; 12(2):289-97. PubMed ID: 1995194
[TBL] [Abstract][Full Text] [Related]
2. Rat pituitary changes observed with magnetic resonance imaging following removal of estrogen stimulus: correlation with histopathology and immunohistology.
van Nesselrooij JH; Szeverenyi NM; Ritter-Hrncirik C; Tillapaugh-Fay GM; Feron VJ
Carcinogenesis; 1992 Feb; 13(2):277-82. PubMed ID: 1740019
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-DTPA-enhanced and digitally subtracted magnetic resonance imaging of estrogen-induced pituitary lesions in rats: correlation with pituitary anatomy.
van Nesselrooij JH; Szeverenyi NM; Tillapaugh-Fay GM; Hendriksen FG
Magn Reson Imaging; 1990; 8(5):525-33. PubMed ID: 2082122
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of estrogen-induced pituitary hypertrophy in rats.
van Nesselrooij JH; Szeverenyi NM; Ruocco MJ
Magn Reson Med; 1989 Aug; 11(2):161-71. PubMed ID: 2779409
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of blood-filled cavities in estrogen-induced anterior pituitary tumors in male Sprague-Dawley rats.
van Nesselrooij JH; Hendriksen GJ; Feron VJ; Bosland MC
Toxicol Pathol; 1992; 20(1):71-80. PubMed ID: 1411134
[TBL] [Abstract][Full Text] [Related]
6. Quantitative magnetic resonance imaging of estradiol-induced pituitary hyperplasia in rats.
Rudin M; Briner U; Doepfner W
Magn Reson Med; 1988 Jul; 7(3):285-91. PubMed ID: 3205145
[TBL] [Abstract][Full Text] [Related]
7. Correlations between presence of spontaneous lesions of the pituitary (adenohypophysis) and plasma prolactin concentration in aged Wistar rats.
van Nesselrooij JH; Kuper CF; Bosland MC
Vet Pathol; 1992 Jul; 29(4):288-300. PubMed ID: 1325082
[TBL] [Abstract][Full Text] [Related]
8. The importance of dopamine in the pathogenesis of experimental prolactinomas.
el-Azouzi M; Hsu DW; Black PM; Jolesz F; Hedley-Whyte ET; Klibanski A; Zervas NT
J Neurosurg; 1990 Feb; 72(2):273-81. PubMed ID: 1967303
[TBL] [Abstract][Full Text] [Related]
9. Glandular kallikrein in estrogen-induced pituitary tumors: time course of induction and correlation with prolactin.
Hatala MA; Powers CA
Cancer Res; 1988 Aug; 48(15):4158-62. PubMed ID: 3390808
[TBL] [Abstract][Full Text] [Related]
10. Regulation of prolactin gene expression in a DMBA-estrogen-induced transplantable rat pituitary tumor.
Lloyd RV; Jin L; Fields K; Kulig E
Am J Pathol; 1990 Dec; 137(6):1525-37. PubMed ID: 2124415
[TBL] [Abstract][Full Text] [Related]
11. [Estrogen-induced pituitary tumors--in relation to the changes in the pituitary gland after estrogen withdrawal].
Kojima M; Hashimoto N; Yamagami T; Handa H
No To Shinkei; 1985 Nov; 37(11):1087-93. PubMed ID: 4074580
[TBL] [Abstract][Full Text] [Related]
12. Salmon calcitonin induces pituitary tumor in rats.
Ishii J; Katayama S; Itabashi A; Takahama M; Kawazu S
Endocrinol Jpn; 1991 Dec; 38(6):705-9. PubMed ID: 1823038
[TBL] [Abstract][Full Text] [Related]
13. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies].
Inagaki H; Hori T
No To Shinkei; 1989 Jun; 41(6):593-601. PubMed ID: 2803826
[TBL] [Abstract][Full Text] [Related]
14. Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.
Strecker TE; Spady TJ; Schaffer BS; Gould KA; Kaufman AE; Shen F; McLaughlin MT; Pennington KL; Meza JL; Shull JD
Genetics; 2005 Apr; 169(4):2189-97. PubMed ID: 15687265
[TBL] [Abstract][Full Text] [Related]
15. Modulation of estrogen action in the rat pituitary and mammary glands by dietary energy consumption.
Spady TJ; Harvell DM; Lemus-Wilson A; Strecker TE; Pennington KL; Vander Woude EA; Birt DF; McComb RD; Shull JD
J Nutr; 1999 Feb; 129(2S Suppl):587S-590S. PubMed ID: 10064338
[TBL] [Abstract][Full Text] [Related]
16. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S
J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236
[TBL] [Abstract][Full Text] [Related]
17. Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17 beta.
Blankenstein MA; Broerse JJ; van Zwieten MJ; van der Molen HJ
Breast Cancer Res Treat; 1984; 4(2):137-41. PubMed ID: 6743839
[TBL] [Abstract][Full Text] [Related]
18. Invasive pituitary tumors in female F344 rats induced by estradiol dipropionate.
Satoh H; Kajimura T; Chen CJ; Yamada K; Furuhama K; Nomura M
Toxicol Pathol; 1997; 25(5):462-9. PubMed ID: 9323835
[TBL] [Abstract][Full Text] [Related]
19. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
[TBL] [Abstract][Full Text] [Related]
20. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
